Incyte Corporation 13D and 13G filings for Prelude Therapeutics Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 4:01 pm Purchase | 2025-11-03 | 13G | Prelude Therapeutics Incorporated PRLD | INCYTE CORP INCY | 4,372,124 9.900% | 4,372,124 (New Position) | Filing |